← Leaderboards
Tracy A Glauser
Children'S Hospital Med Ctr (Cincinnati)
$35,287,551
Attributed
$38,592,230
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.6M · FY2005–25$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$38,592,230 · 11
By mechanism
U01$31,060,683 · 1
U24$2,896,790 · 1
U10$2,132,353 · 1
K12$891,000 · 1
T32$557,191 · 1
K08$483,435 · 1
Top collaborators
- Daniel Woo11 shared
- Sonya C Tang Girdwood6 shared
- Brandon Foreman2 shared
- Pooja Khatri2 shared
- Zachary L Taylor2 shared
Others in their field
Top investigators on “Childhood”
- Gregory H Reaman · National Childhood Cancer Foundation$268,060,146
- Barbara Driver · Westat, Inc.$206,410,885
- Sharon A Nachman · Johns Hopkins University$191,166,598
- Peter C Adamson · National Childhood Cancer Foundation$190,988,407
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$187,267,729
- James E. Gern · University Of Wisconsin-Madison$149,875,125
Research focus
ChildhoodClinical TrialsSiteSkillsClinical ResearchSuccessUnited States National Institutes Of HealthFundingAffectLeadFoundationsAdultTrainingResearch PersonnelRandomizedPediatric HospitalsLeadershipResearch InfrastructurePatient PopulationCollaborationsEpilepsyEnrollmentInstitutionCountry
Grant awards (40)
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)$443,918
U24 · FY2025 · NS · contact PI
Clinical Pharmacology K12 Training Program$297,000
K12 · FY2025 · HD
T32 Cincinnati Pediatric Clinical Pharmacology Training Program$200,870
T32 · FY2025 · HD
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)$430,070
U24 · FY2024 · NS · contact PI
Clinical Pharmacology K12 Training Program$297,000
K12 · FY2024 · HD
T32 Cincinnati Pediatric Clinical Pharmacology Training Program$195,200
T32 · FY2024 · HD
Clinical Research Sites for the Network of Excellence in Neuroscience Clinical Trials (NeuroNEXT sites)$460,240
U24 · FY2023 · NS · contact PI
Clinical Pharmacology K12 Training Program$297,000
K12 · FY2023 · HD
T32 Cincinnati Pediatric Clinical Pharmacology Training Program$161,121
T32 · FY2023 · HD
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$299,546
U24 · FY2022 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$304,502
U24 · FY2021 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$309,724
U24 · FY2020 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$314,790
U24 · FY2019 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$334,000
U24 · FY2018 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$311,500
U10 · FY2017 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$311,500
U10 · FY2016 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$255,500
U10 · FY2015 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$311,500
U10 · FY2014 · NS · contact PI
Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE$938,178
U01 · FY2013 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$308,103
U10 · FY2013 · NS · contact PI
Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE$3,165,569
U01 · FY2012 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$310,000
U10 · FY2012 · NS · contact PI
Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE$4,374,323
U01 · FY2011 · NS · contact PI
Cincinnati Neuroscience Clinical Trials Research Center (CinciNEXT)$324,250
U10 · FY2011 · NS · contact PI
Impact of Initial Therapy and Response on Long Term Outcome in Children with CAE$3,246,560
U01 · FY2010 · NS · contact PI
Childhood Absence Epilepsy Rx, PK-PD-Pharmacogenetics$2,000,000
U01 · FY2009 · NS · contact PI
Childhood Absence Epilepsy Rx, PK-PD-Pharmacogenetics$6,451,910
U01 · FY2008 · NS · contact PI
CLINICAL TRIAL: CHILDHOOD ABSENCE EPILEPSY$100,917
M01 · FY2008 · RR · contact PI
Childhood Absence Epilepsy Rx, PK-PD-Pharmacogenetics$3,119,264
U01 · FY2007 · NS · contact PI
CHILDHOOD ABSENCE EPILEPSY$80,782
M01 · FY2007 · RR · contact PI
CHILDHOOD ABSENCE EPILEPSY$62,025
M01 · FY2006 · RR · contact PI
Childhood Absence Epilepsy Rx, PK-PD-Pharmacogenetics$4,170,091
U01 · FY2005 · NS
CHILDHOOD ABSENCE EPILEPSY$1,844
M01 · FY2005 · RR
Blood Genomics of Anticonvulsant Efficacy in Children$153,733
R21 · FY2004 · NS
Childhood Absence Epilepsy Rx, PK-PD-Pharmacogenetics$3,594,788
U01 · FY2003 · NS
Blood Genomics of Anticonvulsant Efficacy in Children$171,477
R21 · FY2003 · NS
CLINICAL PHARMACOLOGY OF CHILDHOOD EPILEPSY$125,010
K08 · FY2003 · NS
CLINICAL PHARMACOLOGY OF CHILDHOOD EPILEPSY$125,010
K08 · FY2002 · NS
CLINICAL PHARMACOLOGY OF CHILDHOOD EPILEPSY$125,010
K08 · FY2001 · NS
CLINICAL PHARMACOLOGY OF CHILDHOOD EPILEPSY$108,405
K08 · FY2000 · NS